Prediction of metabolic syndrome among postmenopausal Ghanaian women using obesity and atherogenic markers

Table 5 Area under Curves of BMI, WC, WTR, WHR, TG/HDL-C, HDL-C/TC and WHtR for Metabolic Syndrome

	BMI	WC	WTR	WHR	WHtR	TG/HDL-C	HDL-C/TC
*POSTMENOPAUSAL*
Blood Pressure	0.7(0.6-0.9)*	0.6(0.5-0.8)	0.7(0.5-0.8)*	0.4(0.3-0.6)	0.7(0.5-0.8)*	0.6(0.4-0.7)	0.5(0.4-0.7)
Glucose	0.5(0.4-0.6)	0.7(0.6-0.8)*	0.3(0.2-0.4)	0.6(0.5-0.7)*	0.6(0.5-0.7)*	0.8(0.7-0.9)***	0.7(0.6-0.8)*
HDL-C	0.5(0.4-0.6)	0.6(0.5-0.7)	0.4(0.3-0.5)	0.7(0.6-0.8)*	0.5(0.4-0.6)	0.8(0.7-0.9)***	0.8(0.7-0.9)***
Metabolic Syndrome	0.6(0.5-0.7)	0.6(0.5-0.7)*	0.4(0.3-0.5)	0.6(0.5-0.7)*	0.6(0.5-0.7)	0.8(0.7-0.9)***	0.8(0.7-0.9)***
*PREMENOPAUSAL*
Blood Pressure	0.6(0.5-0.7)*	0.6(0.5-0.7)*	0.6(0.5-0.7)	0.6(0.5-0.7)*	0.6(0.5-0.7)*	0.5(0.4-0.6)	0.5(0.4-0.6)
Glucose	0.4(0.3-0.5)	0.5(0.4-0.6)	0.6(0.5-0.7)	0.7(0.6-0.8)*	0.5(0.4-0.6)	0.8(0.7-0.9)***	0.6(0.5-0.8)*
HDL-C	0.5(0.4-0.6)	0.5(0.4-0.6)	0.6(0.5-0.7)	0.7(0.6-0.8)*	0.5(0.4-0.6)	0.7(0.6-0.8)*	0.7(0.6-0.8)***
Metabolic Syndrome	0.5(0.4-0.6)	0.5(0.4-0.6)	0.6(0.5-0.7)	0.6(0.5-0.7)*	0.5(0.4-0.6)	0.8(0.7-0.9)***	0.6(0.5-0.8)*

All values were AUC (95%CI), AUC, area under curves; CI, confidence interval, *P < 0.05. **P < 0.001 **P < 0.0001 Continuous data were presented as mean ± standard error of mean (SEM). HDL-C: High Density Lipoprotein, WHR: Waist-to-Hip Ratio, BMI: Body Mass Index, WTR: Waist-to-Thigh Ratio, WHtR: Waist-to-Height Ratio, WHR: Waist-to-Hip Ratio, BMI: Body Mass Index, WC: Waist Circumference, WTR: Waist-to-Thigh Ratio, WHtR: Waist-to-Height Ratio. Each comparison was performed between pre and postmenopausal women with and without metabolic syndrome.

ISSN: 1476-511X